Coya Therapeutics (COYA) Earnings Date, Estimates & Call Transcripts $5.96 +0.17 (+2.94%) Closing price 07/17/2025 04:00 PM EasternExtended Trading$6.23 +0.27 (+4.53%) As of 08:38 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Coya Therapeutics Earnings Summary Coya Therapeutics issued Q1 2025 earnings on May 13, 2025, reporting an EPS of -$0.44, which hit the consensus estimate of -$0.44. Quarterly revenue was reported to be $257.88 million, above analysts' expectations of $2.63 million. With a trailing EPS of -$1.07, Coya Therapeutics' earnings are expected to decrease next year, from ($1.15) to ($1.47) per share. Upcoming Q2 Earnings DateAug. 11EstimatedConsensus EPS (May. 13) -$0.44 Actual EPS (May. 13) -$0.44 Actual Revenue (May. 13) $257.88MQ1 2025 Earnings ResourcesQ1 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)COYA Upcoming EarningsCoya Therapeutics' Q2 2025 earnings is scheduled for Monday, August 11, 2025, with a conference call scheduled at 7:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q2 2025 Earnings ReportPowered by Get Coya Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Coya Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCOYA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.COYA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Coya Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.44-$0.44-$0.44Q2 20251-$0.22-$0.22-$0.22Q3 20251-$0.24-$0.24-$0.24Q4 20251-$0.51-$0.51-$0.51 FY 2025 4 -$1.41 -$1.41 -$1.41 Q1 20261-$0.50-$0.50-$0.50Q2 20261-$0.46-$0.46-$0.46Q3 20261-$0.48-$0.48-$0.48Q4 20261-$0.49-$0.49-$0.49 Coya Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/11/2025(Estimated)-------5/13/2025Q1 2025-$0.44-$0.44--$0.44$2.63M$257.88M3/18/2025Q4 2024-$0.32-$0.18+$0.14-$0.18$0.10M$0.20M11/6/2024--$0.41-$0.26+$0.15-$0.26$0.30M-8/12/2024Q2 2024--$0.19--$0.19-$3.43M5/9/2024Q1 2024--$0.35--$0.35-$0.13M3/19/2024Q4 2023-$0.15-$0.15-$6.00M11/8/2023Q3 2023--$0.34--$0.34--8/8/2023Q2 2023--$0.31--$0.31-- Coya Therapeutics Earnings - Frequently Asked Questions When is Coya Therapeutics' earnings date? Coya Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 11th, 2025 based off last year's report dates. Learn more on COYA's earnings history. Did Coya Therapeutics beat their earnings estimates last quarter? In the previous quarter, Coya Therapeutics (NASDAQ:COYA) reported ($0.44) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.44). Learn more on analysts' earnings estimate vs. COYA's actual earnings. How much revenue does Coya Therapeutics generate each year? Coya Therapeutics (NASDAQ:COYA) has a recorded annual revenue of $3.55 million. How much profit does Coya Therapeutics generate each year? Coya Therapeutics (NASDAQ:COYA) has a recorded net income of -$14.88 million. COYA has generated -$1.07 earnings per share over the last four quarters. What is Coya Therapeutics' EPS forecast for next year? Coya Therapeutics' earnings are expected to decrease from ($1.15) per share to ($1.47) per share in the next year. More Earnings Resources from MarketBeat Related Companies TECX Earnings Date SLDB Earnings Date ITOS Earnings Date ETON Earnings Date ALT Earnings Date CMPX Earnings Date CYRX Earnings Date RVNC Earnings Date VIGL Earnings Date CTOR Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles How Goldman Sachs Earnings Help You Strategize Your PortfolioCitigroup Earnings Could Signal What’s Next for Markets3 Analysts Set $600 Target Ahead of Microsoft EarningsTesla: 2 Plays Ahead of Next Week's Earnings ReportFastenal Surges After Earnings Beat, Tariff Risks Loom3 Catalysts Converge on Intel Ahead of a Critical Earnings ReportSmith & Wesson Stock Falls on Earnings Miss, Tariff Woes This page (NASDAQ:COYA) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredWhat’s the “Golden Anomaly”… and how can you profit?Trump’s “Big Beautiful Bill” passed! That means the US is on track for $60 trillion in debt by 2035 – by the g...Golden Portfolio | SponsoredNew crypto laws coming. Will you win or lose?Washington’s first-ever “Crypto Week” could trigger a major Bitcoin surge — but one trader says don’t just buy...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | Sponsored“All the land that you see I will give to you and your offspring forever…”“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coya Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Coya Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.